Skip to content
zameds

Indapamide, perindopril

Sold as Preterax, Coversyl plus, Perindopril co unicorn, Spec-perindopril plus, Pearinda plus, Trexeva plus

S3

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
4
Registrations
8
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Servier Laboratories South Africa (Pty) LtdCertificate held by Servier Laboratories SA (Pty) Ltd1 of 3 cancelledPreterax, Coversyl plus, Perindopril co unicorn4mg, 4/1,25330362, 330363, 370356S3PIPIL
Specpharm (Pty) LtdSpec-perindopril plus2, 4410630, 410631S3None
Pharma Dynamics (Pty) LtdPearinda plus4410633S3None
Teva Pharmaceuticals (Pty) LtdCertificate held by Teva Pharmaceuticals (Pty) Ltd.Trexeva plus2,5/0,625, 2,5/0,625 mg & 5/1,25 mg481168, 481169S3PIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Preterax

EACH TABLET CONTAINS INDAPAMIDE 0,625 mg PERINDOPRIL 2,0 mg

Not listed33036233/7.1.3/0362CancelledS3None
Coversyl plus

EACH TABLET CONTAINS INDAPAMIDE 1,25 mg PERINDOPRIL 4,0 mg

4mgTablet33036333/7.1.3/0363Approved 9 April 2020RegisteredS3PIPIL
Perindopril co unicorn 4/1,25

EACH TABLET CONTAINS INDAPAMIDE 1,25 mg PERINDOPRIL 4,0 mg

4/1,2537035637/7.1.3/0356RegisteredS3None
Spec-perindopril plus 2

EACH TABLET CONTAINS INDAPAMIDE 0,625 mg PERINDOPRIL 2,0 mg

241063041/7.1.3/0630RegisteredS3None
Spec-perindopril plus 4

EACH TABLET CONTAINS INDAPAMIDE 1,250 mg PERINDOPRIL 4,0 mg

441063141/7.1.3/0631RegisteredS3None
Pearinda plus 4

EACH TABLET CONTAINS INDAPAMIDE 1,250 mg PERINDOPRIL 4,0 mg

441063341/7.1.3/0633RegisteredS3None
Trexeva plus 2,5/0,625

EACH FILM-COATED TABLET CONTAINS: PERINDOPRIL TOSILATE 2,5 mg INDAPAMIDE 0,625 mg

2,5/0,625Film-coated tablets48116848/7.1.3/1168Approved 8 October 2024RegisteredS3PIPIL
Trexeva plus 5/ 1,25

EACH FILM-COATED TABLET CONTAINS: PERINDOPRIL TOSILATE 5 mg INDAPAMIDE 1,25 mg

2,5/0,625 mg & 5/1,25 mgFilm-coated tablets48116948/7.1.3/1169Approved 8 October 2024RegisteredS3PIPIL

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, matched to the Consolidated Schedules by ingredient, confidence medium.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Indapamide, perindopril

  • S3: Indapamide

    Consolidated Schedules 06 July 2026, line 3780

  • S3: Perindopril

    Consolidated Schedules 06 July 2026, line 4107

Pharmacological class: Other hypotensives. (class 7.1.3)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Coversyl plus, Servier Laboratories South Africa (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsCoversyl plus, Servier Laboratories South Africa (Pty) LtdPatient information leaflet (PIL)For patients and carersCoversyl plus, Servier Laboratories South Africa (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles